Imaging lymphatic function and inflammation response through hypoxia via endogenous biomarker

Marien I. Ochoa, Xu Cao, Matthew S. Reed, Eduard Matkovic, Weifeng Zeng, Samuel O. Poore, Brian W. PogueJournal of Biomedical Optics 2025 · DOI

TL;DR

This paper introduces a novel method for real-time, non-invasive imaging of lymphatic function and inflammation by detecting endogenous hypoxia within lymphatic vessels. This approach utilizes the delayed fluorescence of protoporphyrin IX (PpIX) as a biomarker for low-oxygen conditions, offering a new way to visualize lymphatic dynamics in response to injury and disease.

What Problem Does This Paper Address?

The lymphatic system, crucial for immune function and fluid balance, is notoriously difficult to study due to its subtle, passive nature. Current methods for imaging lymphatic function often rely on exogenous contrast agents, which can be invasive and may not fully capture the dynamic, real-time physiological state of the lymphatics. A key, yet underappreciated, aspect of the lymphatic system is its inherent hypoxia, which arises from its location distant from oxygen-rich blood and its role as a waste reservoir. This hypoxia is linked to important processes like lymphangiogenesis and cancer metastasis. The challenge has been to find a non-invasive way to visualize this hypoxia and, by extension, the functional state of the lymphatics, especially in response to inflammatory or pathological conditions.

Methods

The core innovation of this work is the use of delayed fluorescence (DF) imaging of endogenous protoporphyrin IX (PpIX) as a marker for hypoxia in the lymphatic system. Here's a breakdown of the key techniques:

  • 5-Aminolevulinic Acid (5-ALA) Administration: Mice were administered 5-ALA, a precursor that is metabolized into PpIX within cells. PpIX is naturally produced but its synthesis is boosted by 5-ALA.
  • PpIX Fluorescence: PpIX exhibits both prompt fluorescence (PF) and delayed fluorescence (DF).
  • Prompt Fluorescence (PF): This signal directly correlates with the concentration of PpIX in tissues. It was used to visualize PpIX distribution.
  • Delayed Fluorescence (DF): This signal arises from the triplet state of PpIX and is highly sensitive to oxygen levels. In hypoxic (low oxygen) conditions, the DF signal is amplified because oxygen normally quenches it. This makes DF a direct indicator of hypoxia.
  • Time-Gated Imaging: To isolate the DF signal from the much stronger PF signal, the researchers used a time-gated emICCD camera. This technique captures fluorescence emitted after a specific delay following excitation, effectively filtering out the prompt emission.
  • Macroscopic Imaging: A custom imaging setup was used to capture DF hypoxia signals from the entire mouse, allowing for visualization of lymphatic structures across different body regions.
  • Histology and Immunohistochemistry (IHC): Excised tissues (lymph nodes, tumors, wounds) were analyzed using H&E staining and IHC to confirm the presence of PpIX, hypoxia markers (HIF-1α), and immune cells (macrophages, T cells) in specific locations.
  • Oxygen Probe Measurement: An independent oxygen sensing probe (Oxyphor PdG4) was used to validate the low oxygen levels measured in lymph nodes and wound areas.
  • ICG Lymph Node Mapping: Indocyanine green (ICG) was used as a conventional method to map lymph node locations, allowing for validation of the DF hypoxia imaging results.

Datasets

The study utilized in vivo data from athymic nude mice. These mice were subjected to various conditions:

  • Moderate and severe wound injuries
  • Visually inflamed wounds
  • Tumor xenografts (AsPC1 pancreatic adenocarcinoma)
  • Uninjured, anesthetized, and awake/moving states

The researchers did not introduce new benchmark datasets but rather used their experimental data to demonstrate the capabilities of their imaging technique.

Key Insights and Ideas

  • Lymphatics are Naturally Hypoxic: This study provides the first in vivo documentation of hypoxia within the lymphatic system, suggesting it's a common physiological state, not just a pathological one.
  • DF PpIX as a Universal Hypoxia Sensor: The DF signal from PpIX, induced by 5-ALA, acts as a reliable, endogenous biomarker for localized hypoxia across various tissues, including lymphatics, tumors, and wounds.
  • Movement Enhances Lymphatic Visualization: For uninjured mice, lymphatic signals were significantly enhanced and more easily visualized when the animals were awake and moving, highlighting the dynamic nature of lymphatic function.
  • Immune Cells Play a Role in PpIX Clearance: IHC analysis revealed that PpIX accumulation in lymph nodes co-localized with macrophages and T cells, suggesting these immune cells are involved in clearing PpIX and potentially contribute to the observed lymphatic pulsations.
  • Hypoxia Dynamics Differ Across Tissues: The timing of peak hypoxia intensity in lymph nodes versus tumors differed, suggesting that this technique could potentially differentiate between various hypoxic sources based on temporal analysis.

Key Results

  • Macroscopic Lymphatic Pulsations: The DF hypoxia imaging revealed cyclical pulsations in lymph nodes and lymphatic structures associated with wounds and tumors, occurring at approximately 10 beats per minute (BPM), which is significantly slower than heart or respiration rates.
  • Hypoxia in Inflamed and Tumor Regions: Hypoxia was consistently observed in lymph nodes draining wound areas, near tumors, and within the tumor microenvironment.
  • Validation of Hypoxia: Oxygen probe measurements confirmed significantly lower oxygen levels (~10 mmHg) in lymph nodes compared to normal tissue (~38 mmHg).
  • Correlation with Immune Cells: IHC confirmed that PpIX-hypoxic regions in lymph nodes, tumors, and wounds were associated with the presence of macrophages and T cells.
  • Improved Contrast with Movement: Awake and moving mice showed clearer DF hypoxia signals in lymph nodes compared to anesthetized mice.
  • Wound and Tumor Impact: The presence of wounds and tumors led to increased PpIX accumulation and more pronounced lymphatic pulsations.

Limitations and Future Work

  • Spatial Resolution: The current macroscopic imager lacks the spatial resolution to visualize the fine structures within lymph nodes (e.g., lymphangions, node capsules) that drive movement. Future work aims to develop higher-resolution instruments.
  • ICG Limitations: While ICG was used for validation, it only maps localized injection sites and doesn't provide the same whole-body hypoxia information as the DF PpIX method. Future studies may explore combining modalities or developing better validation techniques.
  • Anesthesia Effects: While efforts were made to standardize anesthesia, its potential impact on lymphatic function and hypoxia needs further investigation, particularly in comparison to 100% oxygen versus air as a carrier gas.
  • ROS Modulation: The role of reactive oxygen species (ROS) in lymphatic response warrants further study.
  • Larger Animal Models: Future work could utilize larger animal models to better represent human lymphatic systems and facilitate imaging during lymphatic surgery.
  • Longitudinal Studies: Investigating the effects of repeated 5-ALA doses and long-term imaging is suggested.
  • Clinical Translation: The use of 5-ALA, an FDA-approved agent, makes this technique promising for clinical applications in assessing lymphedema and other lymphatic diseases.

Summary updated

Abstract

Unlike injection-based regional lymph node mapping, DF hypoxia imaging appears to provide a natural whole-body contrast mechanism, highlighting its potential for visualizing lymphatic function and associated hypoxia dynamics. This original documentation of lymphatic hypoxia has potential applications in surgical guidance, tracking of metastatic tumors, and immune response tracking.
BibTeX
@article{ochoa2025imaging,
  author = {Marien I. Ochoa and Xu Cao and Matthew S. Reed and Eduard Matkovic and Weifeng Zeng and Samuel O. Poore and Brian W. Pogue},
  title = {{Imaging lymphatic function and inflammation response through hypoxia via endogenous biomarker}},
  journal = {Journal of Biomedical Optics},
  year = {2025},
  doi = {10.1117/1.jbo.31.1.016003},
}
Figure